Gilead Sciences Inc (GILD)
67.36
+0.40
(+0.60%)
USD |
NASDAQ |
Apr 23, 14:29
Gilead Sciences Free Cash Flow (Quarterly): 1.954B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.954B |
| September 30, 2023 | 1.633B |
| June 30, 2023 | 2.199B |
| March 31, 2023 | 1.635B |
| December 31, 2022 | 2.386B |
| September 30, 2022 | 2.706B |
| June 30, 2022 | 1.659B |
| March 31, 2022 | 1.593B |
| December 31, 2021 | 3.049B |
| September 30, 2021 | 3.114B |
| June 30, 2021 | 2.197B |
| March 31, 2021 | 2.445B |
| December 31, 2020 | 1.735B |
| September 30, 2020 | 2.095B |
| June 30, 2020 | 2.423B |
| March 31, 2020 | 1.265B |
| December 31, 2019 | 2.377B |
| September 30, 2019 | 2.445B |
| June 30, 2019 | 2.157B |
| March 31, 2019 | 1.34B |
| December 31, 2018 | 2.097B |
| September 30, 2018 | 2.045B |
| June 30, 2018 | 1.276B |
| March 31, 2018 | 2.058B |
| December 31, 2017 | 2.533B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.565B |
| June 30, 2017 | 3.403B |
| March 31, 2017 | 2.807B |
| December 31, 2016 | 3.37B |
| September 30, 2016 | 4.195B |
| June 30, 2016 | 4.781B |
| March 31, 2016 | 3.953B |
| December 31, 2015 | 5.629B |
| September 30, 2015 | 3.81B |
| June 30, 2015 | 5.487B |
| March 31, 2015 | 5.577B |
| December 31, 2014 | 2.854B |
| September 30, 2014 | 3.909B |
| June 30, 2014 | 4.094B |
| March 31, 2014 | 1.404B |
| December 31, 2013 | 658.11M |
| September 30, 2013 | 715.92M |
| June 30, 2013 | 907.73M |
| March 31, 2013 | 633.25M |
| December 31, 2012 | 436.19M |
| September 30, 2012 | 678.78M |
| June 30, 2012 | 1.253B |
| March 31, 2012 | 429.77M |
| December 31, 2011 | 952.00M |
| September 30, 2011 | 832.82M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
1.265B
Minimum
Mar 2020
3.114B
Maximum
Sep 2021
2.161B
Average
2.197B
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 289.00M |
| Johnson & Johnson | 5.804B |
| Eli Lilly and Co | -1.963B |
| Pfizer Inc | 4.196B |
| CymaBay Therapeutics Inc (DELISTED) | -27.56M |